v3.26.1
Organization and Description of Business (Details)
$ in Thousands
12 Months Ended 35 Months Ended
Dec. 30, 2024
USD ($)
Dec. 31, 2025
USD ($)
shares
Dec. 31, 2024
USD ($)
shares
Dec. 31, 2025
USD ($)
shares
Dec. 31, 2025
£ / shares
Dec. 31, 2025
USD ($)
shares
Dec. 31, 2024
£ / shares
Dec. 31, 2024
USD ($)
shares
Jan. 27, 2023
USD ($)
Subsidiary, Sale of Stock [Line Items]                  
Accumulated deficit           $ (1,186,234)   $ (988,702)  
Repayments of debt   $ 0 $ 110,097            
Ordinary shares, nominal value (in pound sterling per share) | £ / shares         £ 0.002   £ 0.002    
Cash and cash equivalents and short-term investments           $ 577,100      
Sufficient funding term (at least)   12 months              
ATM Program                  
Subsidiary, Sale of Stock [Line Items]                  
Sale of stock, consideration receivable (up to)                 $ 250,000
Shares sold in offering (in shares) | shares   372,538   4,663,354          
Aggregate net proceeds from shares sold   $ 6,100   $ 36,600          
Underwriter Offering                  
Subsidiary, Sale of Stock [Line Items]                  
Shares sold in offering (in shares) | shares   13,372,093 29,932,626            
Aggregate net proceeds from shares sold   $ 269,200 $ 349,900            
Number of shares issued per ordinary share (in shares) | shares           1   1  
Ordinary shares, nominal value (in pound sterling per share) | £ / shares         £ 0.002   £ 0.002    
Secured Debt | Line of Credit                  
Subsidiary, Sale of Stock [Line Items]                  
Debt issuance costs $ (1,100)                
Additional amount of loan proceeds $ 40,000                
Clinical milestone (in days) 90 days                
Additional amount available to borrowers $ 50,000                
Term Loan Facility                  
Subsidiary, Sale of Stock [Line Items]                  
Aggregate principal amount 200,000                
Proceeds from issuance of debt 110,000                
Additional amount of loan proceeds 40,000                
Additional amount available to borrowers 50,000                
Repayments of debt $ 110,000